ValuEngine upgraded shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday.

Separately, Zacks Investment Research upgraded shares of Vitamin Shoppe from a sell rating to a hold rating in a research note on Wednesday, August 1st.

Shares of VSI stock opened at $12.15 on Tuesday. The company has a current ratio of 1.96, a quick ratio of 0.32 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $294.65 million, a PE ratio of 30.91 and a beta of 0.74. Vitamin Shoppe has a 52-week low of $2.95 and a 52-week high of $13.95.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, August 8th. The specialty retailer reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.04 by $0.27. The company had revenue of $293.10 million for the quarter, compared to analysts’ expectations of $279.87 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%. equities analysts forecast that Vitamin Shoppe will post 0.13 earnings per share for the current year.

In related news, Director Guillermo Marmol purchased 8,900 shares of the firm’s stock in a transaction that occurred on Friday, August 10th. The shares were acquired at an average price of $11.21 per share, for a total transaction of $99,769.00. Following the purchase, the director now owns 49,479 shares in the company, valued at $554,659.59. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sharon M. Leite purchased 5,500 shares of the firm’s stock in a transaction that occurred on Friday, August 31st. The stock was bought at an average price of $12.64 per share, for a total transaction of $69,520.00. Following the purchase, the chief executive officer now owns 5,500 shares in the company, valued at approximately $69,520. The disclosure for this purchase can be found here. 18.50% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP grew its stake in Vitamin Shoppe by 10.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock valued at $7,288,000 after buying an additional 158,123 shares during the last quarter. Millennium Management LLC acquired a new position in shares of Vitamin Shoppe during the 1st quarter worth approximately $1,628,000. Tamarack Advisers LP acquired a new position in shares of Vitamin Shoppe during the 1st quarter worth approximately $4,870,000. AJ Wealth Strategies LLC acquired a new position in shares of Vitamin Shoppe during the 2nd quarter worth approximately $266,000. Finally, California Public Employees Retirement System grew its position in shares of Vitamin Shoppe by 5.0% during the 1st quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock worth $1,230,000 after purchasing an additional 13,338 shares in the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Further Reading: Return on Investment (ROI) Defined, Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.